The primary aim is to characterize the longitudinal change on the cognitive, clinical, and biomarker measures used in the A4 trial in Aβne individuals in comparison to the Aβe A4 placebo arm individuals.
|Effective start/end date||11/1/15 → 4/30/23|
- University of Southern California (68294071//LEARN-15-396727)
- National Alzheimer's Association (68294071//LEARN-15-396727)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.